Skip to content

Real-life Evaluation of the Safety and Performance of EUROTEKNIKA Dental Implants

Real-life Evaluation of the Safety and Performance of EUROTEKNIKA Dental Implants

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05375045
Enrollment
868
Registered
2022-05-16
Start date
2022-03-25
Completion date
2028-02-01
Last updated
2022-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Edentulous Mouth

Brief summary

Real-life evaluation of the safety and performance of EUROTEKNIKA dental implants

Detailed description

Many adults have one or more missing teeth. The negative consequences of partial or total edentulousness are numerous at the level of the orofacial sphere : * Edentulism generates a strong aesthetic deficit due to the lack of support of the tissues and the facial musculature; * Edentulism causes a functional deficit that can have significant repercussions on the nutritional status of the affected subject; * Edentulism is accompanied by bone resorption of the jaws which is unavoidable in the absence of implant treatment; * In addition, the resulting feelings of discomfort and fragility are experienced as a real psychological handicap by the patient, partially or totally edentulous, which can then have significant repercussions on his social life. EUROTEKNIKA dental implants are intended to be used for the replacement of a dental root in order to support a fixed or mobile prosthesis and thus restore masticatory function. EUROTEKNIKA dental implants are made of titanium or titanium alloy for surgical implants in accordance with ISO5832-2 and -3 standards. EUROTEKNIKA dental implants are intended for use in cases of single, partial or complete edentulism on the maxillary and/or mandibular arch: * Single tooth loss, * Intercalary toothlessness, * Terminal toothlessness, * Total edentulism. Dental implantology is based on the following principle: an implant is surgically inserted into the maxilla or mandible, and then a pillar is connected to this implant to support the dental prosthesis. The use of dental implants is based on a biological process called osseointegration. Osseointegration corresponding to the fact that certain materials such as titanium are able to form direct contact with the surrounding bone. Osseointegration is therefore the direct structural and functional connection between living bone and the surface of an artificial implant. In order to allow the osseointegration process, and depending on the clinical case, a more or less long healing period must be observed before connecting the prosthetic elements to the implant. In cases of immediate loading, there is no healing period. The expected benefits of this surgery are to improve the quality of life of patients and to recover masticatory function. The claimed clinical performances are: * High primary stability, * High long-term implant stability, * Limitation of bone resorption and risks of mucositis and peri-implantitis * Maintenance of soft tissues. The objectives of this study are therefore to assess the safety and performance of EUROTEKNIKA dental implants.

Interventions

DEVICEdental implantation

an implant is surgically inserted into the maxilla or mandible, and then an abutment is connected to this implant to support the dental prosthesis.

Sponsors

EVAMED
CollaboratorOTHER
Euroteknika
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient aged 18 or over * Patient who has completed bone growth * Patient informed and agreeing to participate in the study * Partially or totally edentulous patient who will be implanted with the EUROTEKNIKA dental implant (for the prospective cohort) * Patient to benefit from the placement of an implant for the creation of a single crown (for the prospective cohort) * Patient implanted with the EUROTEKNIKA dental implant before 2017 (for the retrospective cohort) * Patient having benefited from the placement of an implant for the creation of a single crown (for the retrospective cohort)

Exclusion criteria

* Pregnant or breastfeeding women (for the prospective cohort) * Patient with bone disease in the cervico-facial region * Patient refusing to participate in the study * Patient with at least one contraindication to implantation (for the prospective cohort) * Patient to benefit from the placement of an implant with immediate or early loading (for the prospective cohort) * Patient to benefit from the placement of an implant for the support of the bridge, piles, attachment (for the prospective cohort) * Patient having benefited from the placement of an implant with immediate or early loading (for the retrospective cohort) * Patient having benefited from the placement of an implant for the support of the bridge, piles, attachment (for the retrospective cohort)

Design outcomes

Primary

MeasureTime frameDescription
The success rate of tissue integration of the implant5 years after implantationIntegration of the implant 5 years after implantation

Secondary

MeasureTime frameDescription
Complication rate taking into account pain, local tenderness, infection, mobility of the implant, fracture5 years after implantationpain, local tenderness, infection, mobility of the implant, fracture will be collected during the 5 years follow-up
measuring chewing function after prosthesis placement5 years after implantationOcclusal assessment will be performed after implantation and at 5 years follow-up
Rate of inflammation (visual)5 years after implantationAssessment of inflammation with visual examination 5 years after implantation
assessment of the quality of life of patients following the recovery of full dentition with the GOHAI score (General Oral Health Assessment Index)5 years after implantationthe quality of life of patients will be evaluated with the GOHAI score before implantation and 5 years after implantation
assessment of the osseointegration of the implant5 years after implantationassessment of the osseointegration of the implant with the ISQ score
Rate of infection (x-ray)5 years after implantationAssessment of infection with radiographic examination 5 years after implantation
Assessment of the evolution of the péri-implant tissues5 years after implantationassessment of the evolution of the péri-implant tissues with the Pink esthetic score

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026